ECS Botanics is rolling out a series of marketing videos to boost sales from local and international customers as it eyes another consecutive quarter of revenue growth.
The videos highlight the company’s operations, manufacturing practices, product benefits and management team and will be distributed to existing customers and new business leads.
ECS is on track to generate around A$2 million in revenue during Q3 FY2022, up nearly 40% on the previous quarter and a 440% increase on the previous corresponding period.
The company said the increase was driven by sales of its dried flower and oil products, a trend it predicted would continue given ongoing demand.
Medicinal cannabis revenue growth continues to outpace that of the firm’s hemp food and wellness division, giving it a much greater share of sales. During the same period last year, ECS generated 100% of its revenue from hemp food and wellness, compared to around 20% in the current quarter.
The firm said this reflected a transition to a medicinal cannabis-dominant business, providing greater margins and long-term value for shareholders.
Managing director Alex Keach said: “Our seed-to-GMP product business model for the B2B market continues to resonate with a range of customers, and this has allowed the company to unlock a number of… opportunities to underpin revenue growth.
He added ECS was benefitting from consolidation in the industry by onboarding new customers.
